Abstract
1. Heart rate and blood pressure changes following the administration of alinidine 30 mg alone and in combination with atenolol 25 mg, nifedipine retard 20 mg and glyceryl trinitrate 500 micrograms were investigated in three groups of six healthy male volunteers. 2. Concomitant administration of alinidine and atenolol reduced (P less than 0.05) supine, standing and exercise heart rate when compared with alinidine alone. The maximum reduction in exercise heart rate was 116 +/- 2.4 beats min-1 for the combination vs 129.0 +/- 3.1 beats min-1 for alinidine alone. 3. Supine (3, 4, 8 h) and standing (2 h) systolic BP were also reduced (P less than 0.05) with the alinidine and atenolol combination compared with alinidine alone. Little change occurred in diastolic blood pressure. 4. Alinidine and nifedipine in combination reduced (P less than 0.05) the nifedipine induced increase in heart rate in the supine (2, 4 h) and standing (4 h) position and following exercise (2, 4 h). No further decreases in systolic and diastolic blood pressure occurred with the combination. 5. Alinidine administered 2 h before a glyceryl trinitrate challenge reduced (P less than 0.05) the glyceryl trinitrate induced increase in standing heart rate at all time intervals (1 to 6 min); the maximum reduction occurred at 3 min (105.0 +/- 4.3 (glyceryl trinitrate) vs 86.8 +/- 6.7 beats min-1 (combination]. Systolic blood pressure was further reduced at all time intervals with glyceryl trinitrate taken in the presence of alinidine.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Auböck J., Konzett H., Olbrich E. The effect of alinidine (St 567) on emotionally induced tachycardia in man. Eur J Clin Pharmacol. 1982;21(6):467–471. doi: 10.1007/BF00542040. [DOI] [PubMed] [Google Scholar]
- Harron D. W., Riddell J. G., Shanks R. G. Alinidine reduces heart-rate without blockade of beta-adrenoceptors. Lancet. 1981 Feb 14;1(8216):351–353. doi: 10.1016/s0140-6736(81)91672-x. [DOI] [PubMed] [Google Scholar]
- Harron D. W., Shanks R. G. Pharmacology, clinical pharmacology and potential therapeutic uses of the specific bradycardiac agent alinidine. Eur Heart J. 1985 Sep;6(9):722–729. doi: 10.1093/oxfordjournals.eurheartj.a061932. [DOI] [PubMed] [Google Scholar]
- Kobinger W., Lillie C., Pichler L. Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic action. Eur J Pharmacol. 1979 Sep 15;58(2):141–150. doi: 10.1016/0014-2999(79)90005-0. [DOI] [PubMed] [Google Scholar]
- Kobinger W., Lillie C., Pichler L. N-Allyl-derivative of clonidine, a substance with specific bradycardic action at a cardiac site. Naunyn Schmiedebergs Arch Pharmacol. 1979 Apr;306(3):255–262. doi: 10.1007/BF00507111. [DOI] [PubMed] [Google Scholar]
- Löllgen H., Just H., Wollschläger H., Kersting F. [Hemodynamic actions on alinidine during exercise in patients with coronary artery disease]. Z Kardiol. 1981 May;70(5):425–428. [PubMed] [Google Scholar]
- Schurmans J., Piessens J., Kesteloot H., De Geest H. Comparative effects of alinidine and propranolol in ischaemic heart disease. Eur J Clin Pharmacol. 1982;23(5):389–396. doi: 10.1007/BF00605987. [DOI] [PubMed] [Google Scholar]
- Simoons M. L., Balakumaran K. The effects of drugs on the exercise electrocardiogram. Cardiology. 1981;68 (Suppl 2):124–132. doi: 10.1159/000173327. [DOI] [PubMed] [Google Scholar]
- Simoons M. L., Tummers J., van Meurs-van Woezik H., van Domburg R. Alinidine, a new agent which lowers heart rate in patients with angina pectoris. Eur Heart J. 1982 Dec;3(6):542–545. doi: 10.1093/oxfordjournals.eurheartj.a061350. [DOI] [PubMed] [Google Scholar]
- Zimpfer M., Fitzal S., Semsroth M. Relative roles of heart rate and ventricular stroke volume for the regulation of cardiac output during controlled hypotension with sodium nitroprusside in man. Eur J Clin Invest. 1982 Feb;12(1):9–13. doi: 10.1111/j.1365-2362.1982.tb00933.x. [DOI] [PubMed] [Google Scholar]